Rabbit Anti-human Thymocyte Immunoglobulin

兔抗人胸腺细胞免疫球蛋白

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRabbit Anti-human Thymocyte Immunoglobulin
Drug Alias Name即复宁Thymoglobuline
ClassificationBiologics > Protein drugs > Immunoglobulin
Mechanisms of ActionImmunosuppressants
TargetsNot applicable
Therapy Area/IndicationsRejection of organ transplantationDiabetes Mellitus, Type 1Anemia, Aplastic
Global Approved IndicationsRejection of organ transplantationAnemia, Aplastic
Approved Indications in ChinaRejection of organ transplantationAnemia, Aplastic
Original Approved Country/TerritoryMainland China
Original Approved Date2014/04/22
Country/TerritoryBelgiumSloveniaItaly +[9] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesUniversitaire Ziekenhuizen LeuvenGenzyme Europe Bv
Inactive CompaniesN/A
Active IndicationsRejection of organ transplantationDiabetes Mellitus, Type 1Anemia, Aplastic
Inactive IndicationsN/A

Other Information

ATC CodeL04AA04
Related LinksN/A